Zealand Pharma Informs of New Sanofi (France) (SAN.PA) Scientific Presentations for Lyxumia® and of Own Presentation of a Novel Zealand Liquid Glucagon Analogue at the American Diabetes Association’s 73rd Scientific Sessions
6/17/2013 9:07:52 AM
More...
|
Biodel Inc. (BIOD) Announces Data Presentations at American Diabetes Association Annual Meeting
6/17/2013 8:58:27 AM
More...
|
Elcelyx Therapeutics to Present Clinical Data on NewMet™ in Type 2 Diabetes at the 2013 American Diabetes Association Scientific Sessions
6/17/2013 8:43:24 AM
More...
|
Boehringer Ingelheim Corporation and Eli Lilly and Company (LLY) Statement on the American Diabetes Association Request for Independent Review of Incretin-Based Therapies
6/14/2013 10:06:52 AM
More...
|
AstraZeneca PLC (AZN) and Bristol-Myers Squibb Company (BMY) to Present New Data at American Diabetes Association 73rd Scientific Sessions®
6/14/2013 7:07:53 AM
More...
|
Intarcia Therapeutics, Inc. Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
6/13/2013 3:06:40 PM
More...
|
Eli Lilly and Company (LLY) to Highlight Late-Stage Pipeline Molecules at the 73rd American Diabetes Association Scientific Sessions
6/11/2013 1:10:55 PM
More...
|
Boehringer Ingelheim GmbH and Eli Lilly and Company (LLY) Alliance to Feature 34 Presentations in Type 1 and Type 2 Diabetes at the 73rd American Diabetes Association Scientific Sessions®
6/11/2013 6:53:52 AM
More...
|
NeuroMetrix, Inc. (NURO) to Exhibit at American Diabetes Association’s 73rd Scientific Sessions
6/11/2013 6:42:24 AM
More...
|
Transitions Optical and Visionworks® Collaborate With the American Diabetes Association to Continue Eye Health Education Efforts
5/24/2013 9:59:33 AM
More...
|
|